Get started
Author

Laura Cubas-Núñez

Observed names: Cubas Núñez, Laura, L. Cubas, L. Cubas-Nuñez, Laura Cubas, Laura Cubas Nuñez, Laura Cubas-Nuñez
Observed institutions: Universitat de València, Hospital Universitari i Politècnic La Fe, Hospital Clínico Universitario de Valencia, Hospital Universitario Puerta de Hierro Majadahonda, Institut d'Investigació Biomèdica de Girona, Hospital Universitario Doctor Peset, Instituto de Investigación Sanitaria La Fe
ORCID: 0000-0003-4934-3891
Observed ORCID: 0000-0003-4934-3891
OpenAlex ID: A5015882829
Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: Reversed by anti-TNF-α treatment
2019 · Tiziano Balzano, Sherry Dadsetan, et al. · Journal of Hepatology · 126
Reducing Peripheral Inflammation with Infliximab Reduces Neuroinflammation and Improves Cognition in Rats with Hepatic Encephalopathy
2016 · Sherry Dadsetan, Tiziano Balzano, et al. · Frontiers in Molecular Neuroscience · 93
PDF
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
2019 · Sara Gil-Perotin, Jessica Castillo-Villalba, et al. · Frontiers in Neurology · 79
PDF
Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway
2020 · Tiziano Balzano, Yaiza M. Arenas, et al. · Journal of Neuroinflammation · 51
PDF
Potential Role of CHI3L1+ Astrocytes in Progression in MS
2021 · Laura Cubas-Núñez, Sara Gil-Perotín, et al. · Neurology Neuroimmunology & Neuroinflammation · 49
PDF
CSF chitinase 3-like-1 association with disability of primary progressive MS
2020 · Francisco Pérez-Miralles, Daniel Prefasi, et al. · Neurology Neuroimmunology & Neuroinflammation · 37
PDF
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
2022 · Jéssica Castillo-Villalba, Sara Gil-Perotín, et al. · Frontiers in Immunology · 25
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
2022 · Carmen Alcalá, Carlos Quintanilla-Bordás, et al. · Journal of Neurology · 23
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Multiple Sclerosis and Related Disorders · 10
Renal function’s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Neurological Sciences · 8
Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
2019 · Laura Navarro Cantó, Sara Carratalá Boscá, et al. · Frontiers in Neurology · 8
PDF
Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
2023 · Lourdes Álvarez-Sánchez, Carmen Peña-Bautista, et al. · International Journal of Molecular Sciences · 7
PDF
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm
2023 · Jordi Tortosa-Carreres, Anna Quiroga-Varela, et al. · Multiple Sclerosis and Related Disorders · 7
Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
2018 · Sara Gil-Perotin, Jéssica Castillo-Villalba, et al. · Frontiers in Neurology · 7
PDF
Oligoclonal M bands unveil occult inflammation in multiple sclerosis
2022 · Bonaventura Casanova, Jessica Castillo, et al. · Multiple Sclerosis and Related Disorders · 6
NFL during acute spinal cord lesions in MS: a hurdle for the detection of inflammatory activity
2022 · C. Alcalá, L. Cubas, et al. · Journal of Neurology · 6
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays
2025 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 5
New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort
2025 · Lourdes Álvarez‐Sánchez, Laura Ferré‐González, et al. · European Journal of Clinical Investigation · 5
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels
2024 · Carlos Quintanilla-Bordás, Laura Cubas-Núñez, et al. · Frontiers in Neurology · 5
PDF
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
2022 · Carmen Alcalá Vicente, Laura Lacruz, et al. · Frontiers in Neurology · 5
PDF
In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
2017 · Laura Cubas-Nuñez, María Duran-Moreno, et al. · Frontiers in Cellular Neuroscience · 5
PDF
Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report
2024 · Carlos Quintanilla-Bordás, David Gorriz, et al. · Frontiers in Immunology · 4
PDF
Comparative Assessment of Simoa and Lumipulse for Measuring Serum Neurofilament Light Chain in Multiple Sclerosis Patients
2024 · Raquel Gasque-Rubio, Laura Cubas-Nuñez, et al. · Acta Neurologica Scandinavica · 4
PDF
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study
2024 · Carlos Quintanilla-Bordás, Matías Fernández-Patón, et al. · Neurological Sciences · 2
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
2024 · Jordi Tortosa-Carreres, Laura Cubas-Núñez, et al. · Journal of Neuroimmunology · 2
Works count: 36
Citation count: 590
H-index: 9
I10-index: 9
Year
Topic
Type